Skip to main content
Premium Trial:

Request an Annual Quote

Serono Pays Inpharmatica $1.5M As Part of Newly Expanded Proteomics Alliance

NEW YORK, Nov. 16 (GenomeWeb News) - Inpharmatica and Serono have expanded for a third time a collaboration to develop secreted proteins using Inpharmatica's PharmaCarta platform, the firms said today.


Terms of the expanded deal call for Serono to pay Inpharmatica $1.5 million for granting Serono "additional rights" to Inpharmatica's protein sequences.


Additionally, Inpharmatica stands to gain undisclosed up-font payments, milestone payments, and royalties from any resulting products, the companies said.


The original two-year deal, struck in 2001, was expanded by one year in January 2003, and again for a single year in August 2003.


The recent expansion, which extends the alliance for an additional year, will seek to validate the more than 200 protein sequences the companies have jointly identified.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.